Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Feb 20, 2025

BUY
$145.48 - $167.38 $8,001 - $9,205
55 Added 2.31%
2,436 $395 Million
Q2 2024

Feb 20, 2025

SELL
$144.38 - $157.78 $36,383 - $39,760
-252 Reduced 9.57%
2,381 $348 Million
Q1 2024

Feb 20, 2025

SELL
$155.22 - $162.74 $20,799 - $21,807
-134 Reduced 4.84%
2,633 $416 Million
Q4 2023

Feb 20, 2025

SELL
$145.6 - $158.88 $871,998 - $951,532
-5,989 Reduced 68.4%
2,767 $434 Million
Q3 2023

Feb 20, 2025

BUY
$155.75 - $174.48 $993,217 - $1.11 Million
6,377 Added 268.05%
8,756 $1.36 Billion
Q2 2023

Feb 20, 2025

BUY
$154.35 - $166.11 $367,198 - $395,175
2,379 New
2,379 $394 Million
Q1 2023

Feb 20, 2025

SELL
$151.05 - $180.26 $20,844 - $24,875
-138 Reduced 5.06%
2,590 $401 Million
Q4 2022

Feb 20, 2025

SELL
$160.2 - $179.79 $187,914 - $210,893
-1,173 Reduced 30.07%
2,728 $482 Million
Q3 2022

Feb 20, 2025

SELL
$161.33 - $179.52 $156,167 - $173,775
-968 Reduced 19.88%
3,901 $637 Million
Q2 2022

Feb 20, 2025

SELL
$168.19 - $186.01 $30,946 - $34,225
-184 Reduced 3.64%
4,869 $864 Million
Q1 2022

Feb 20, 2025

SELL
$158.14 - $179.59 $216,968 - $246,397
-1,372 Reduced 21.35%
5,053 $895 Million
Q4 2021

Feb 20, 2025

BUY
$155.93 - $173.01 $508,799 - $564,531
3,263 Added 103.19%
6,425 $1.1 Billion
Q3 2021

Feb 20, 2025

BUY
$161.5 - $179.47 $42,313 - $47,021
262 Added 9.03%
3,162 $510,000
Q2 2021

Feb 20, 2025

SELL
$159.48 - $171.07 $3,349 - $3,592
-21 Reduced 0.72%
2,900 $478 Million
Q1 2021

Feb 20, 2025

BUY
$153.07 - $170.48 $101,791 - $113,369
665 Added 29.48%
2,921 $480 Million
Q4 2020

Feb 20, 2025

BUY
$137.11 - $157.38 $48,674 - $55,869
355 Added 18.67%
2,256 $355 Million
Q3 2020

Feb 20, 2025

BUY
$140.38 - $153.83 $266,862 - $292,430
1,901 New
1,901 $283 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $424B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Clare Market Investments LLC Portfolio

Follow Clare Market Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clare Market Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clare Market Investments LLC with notifications on news.